Steris (STE) Reaches New 52-Week High at $124.26
Steris PLC (NYSE:STE) reached a new 52-week high during mid-day trading on Friday . The company traded as high as $124.26 and last traded at $123.98, with a volume of 4615 shares trading hands. The stock had previously closed at $123.55.
A number of research firms have recently issued reports on STE. Stephens reissued a “buy” rating and issued a $135.00 price target on shares of Steris in a research note on Thursday, February 14th. JMP Securities reissued a “buy” rating and issued a $135.00 price target on shares of Steris in a research note on Thursday, February 14th. Finally, Sidoti boosted their price target on shares of Steris from $155.00 to $157.00 and gave the company a “buy” rating in a research note on Thursday, December 6th. Five research analysts have rated the stock with a buy rating, The stock currently has a consensus rating of “Buy” and a consensus price target of $138.20.
The company has a market capitalization of $10.44 billion, a price-to-earnings ratio of 29.73 and a beta of 1.07. The company has a debt-to-equity ratio of 0.40, a quick ratio of 1.99 and a current ratio of 2.56.
The firm also recently announced a quarterly dividend, which will be paid on Thursday, March 21st. Investors of record on Wednesday, February 27th will be paid a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a yield of 1.10%. The ex-dividend date of this dividend is Tuesday, February 26th. Steris’s payout ratio is currently 32.77%.
In related news, Director Michael B. Wood sold 3,609 shares of the company’s stock in a transaction that occurred on Friday, March 1st. The shares were sold at an average price of $121.79, for a total transaction of $439,540.11. The sale was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, VP John Adam Zangerle sold 1,750 shares of the company’s stock in a transaction that occurred on Friday, January 11th. The stock was sold at an average price of $110.00, for a total transaction of $192,500.00. Following the sale, the vice president now directly owns 32,546 shares in the company, valued at $3,580,060. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 10,396 shares of company stock worth $1,226,593. 2.38% of the stock is owned by insiders.
A number of institutional investors and hedge funds have recently made changes to their positions in STE. Oregon Public Employees Retirement Fund grew its holdings in Steris by 10,585.0% during the 4th quarter. Oregon Public Employees Retirement Fund now owns 3,572,743 shares of the medical equipment provider’s stock worth $33,000 after acquiring an additional 3,539,306 shares in the last quarter. Norges Bank acquired a new position in Steris during the 4th quarter worth approximately $96,648,000. Federated Investors Inc. PA grew its holdings in Steris by 2,546.2% during the 3rd quarter. Federated Investors Inc. PA now owns 868,434 shares of the medical equipment provider’s stock worth $99,348,000 after acquiring an additional 835,616 shares in the last quarter. BlackRock Inc. grew its holdings in Steris by 10.3% during the 4th quarter. BlackRock Inc. now owns 8,549,361 shares of the medical equipment provider’s stock worth $913,498,000 after acquiring an additional 800,900 shares in the last quarter. Finally, Villere ST Denis J & Co. LLC acquired a new position in Steris during the 4th quarter worth approximately $63,124,000. 87.10% of the stock is currently owned by hedge funds and other institutional investors.
TRADEMARK VIOLATION NOTICE: “Steris (STE) Reaches New 52-Week High at $124.26” was posted by Daily Political and is the sole property of of Daily Political. If you are accessing this article on another website, it was stolen and reposted in violation of international copyright & trademark legislation. The legal version of this article can be accessed at https://www.dailypolitical.com/2019/03/17/steris-ste-reaches-new-52-week-high-at-124-26.html.
About Steris (NYSE:STE)
STERIS plc provides infection prevention and other procedural products and services worldwide. The company operates in four segments: Healthcare Products, Healthcare Specialty Services, Life Sciences, and Applied Sterilization Technologies. The Healthcare Products segment offers cleaning chemistries and sterility assurance products; accessories for gastrointestinal (GI) procedures, washers, sterilizers, and other pieces of capital equipment for the operations of a sterile processing department; and equipment used in the operating room, including surgical tables, lights, equipment management services, and connectivity solutions.
Receive News & Ratings for Steris Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris and related companies with MarketBeat.com's FREE daily email newsletter.